Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55
In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew
DRG Regulation Opponents May Have Powerful New Ally
DRCCA Staff Boom To 145, Still Growing, Still Looking for People
SSO Education Group Lists “Major Unmet Needs, Problems”
RFA On Breast Cancer Low Fat Diet Available
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









